Relationship of pulmonary function response to ozone exposure and capsaicin cough sensitivity

Inhalation Toxicology

Volumn 25, Issue 10, 2013, Pages 569-576

  Hoffmeyer, Frank ^a   Sucker, Kirsten ^a   Monsé, Christian ^a   Berresheim, Hans ^a   Rosenkranz, Nina ^a   Jettkant, Birger ^a   Beine, Alexandra ^a   Brüning, Thomas ^a   Bünger, Jürgen ^a  

^a RUHR UNIVERSITY BOCHUM   (Germany)

Author keywords

Capsaicin; Neurogenic inflammation; Ozone; Pulmonary function

Indexed keywords

CAPSAICIN; OZONE;

ADULT; AIRWAY RESISTANCE; ARTICLE; CONCENTRATION (PARAMETERS); CORRELATIONAL STUDY; COUGHING; DOSE RESPONSE; ENVIRONMENTAL EXPOSURE; EXERCISE; FEMALE; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; HUMAN; HUMAN EXPERIMENT; LUNG FUNCTION; MALE; MAXIMAL EXPIRATORY FLOW; NERVE FIBER; NORMAL HUMAN; PEAK EXPIRATORY FLOW; PRIORITY JOURNAL; SENSITIVITY ANALYSIS;

EID: 84881496096     PISSN: 08958378     EISSN: 10917691     Source Type: Journal    
DOI: 10.3109/08958378.2013.812699     Document Type: Article

References (36)

1. American Thoracic Society. (1995). Standardization of Spirometry, 1994 update. Am J Respir Crit Care Med 152:1107-36.
2. Aris RM, Tager I, Christian D, et al. (1995). Methacholine responsiveness is not associated with O3-induced decreases in FEV1. Chest 107: 621-8.
3. Balmes JR, Chen LL, Scannell C, et al. (1996). Ozone-induced decrements in FEV1 and FVC do not correlate with measures of inflammation. Am J Respir Crit Care Med 15:904-9. (Pubitemid 26081637)
4. Baur X, Huber H, Degens PO, et al. (1998). Relation between occupational asthma case history, bronchial methacholine challenge, and specific challenge test in patients with suspected occupational asthma. Am J Ind Med 33:114-22. (Pubitemid 28028148)
5. Bennett WD, Hazucha MJ, Folinsbee LJ, et al. (2007). Acute pulmonary function response to ozone in young adults as a function of body mass index. Inhal Toxicol 19:1147-54. (Pubitemid 350072469)
6. Blomberg A, Mudway IS, Nordenhall C, et al. (1999). Ozone-induced lung function decrements do not correlate with early airway inflammatory or antioxidant responses. Eur Respir J 13:1418-28. (Pubitemid 29357163)
7. Canning BJ, Fischer A. (2001). Neural regulation of airway smooth muscle tone. Respir Physiol 125:113-27. (Pubitemid 32184648)
8. Chitano P, Hosselet JJ, Mapp CE, Fabbri LM. (1995). Effect of oxidant air pollutants on the respiratory system: insights from experimental animal research. Eur Respir J 8:1357-71.
9. Hazbun ME, Hamilton R, Holian A, Eschenbacher WL. (1993). Ozoneinduced increases in substance P and 8-epi-prostaglandin F2 alpha in the airways of human subjects. Am J Respir Cell Mol Biol 9:568-72.
10. Hazucha MJ, Bates DV, Bromberg PA. (1989). Mechanism of action of ozone on the human lung. J Appl Physiol 67:1535-41. (Pubitemid 19276408)
11. Hazucha MJ, Folinsbee LJ, Bromberg PA. (2003). Distribution and reproducibility of spirometric response to ozone by gender and age. J Appl Physiol 95:1917-25. (Pubitemid 37310376)
12. Hoffmeyer F, Sucker K, Rosenkranz N, et al. (2013). Reproducibility of sensitivity to capsaicin assessed by single breath inhalation methodology. Adv Exp Med Biol 755:71-8.
13. Johansson A, Lowhagen O, Millqvist E, Bende M. (2002). Capsaicin inhalation test for identification of sensory hyperreactivity. Respir Med 96:731-5.
14. Kafoury RM, Pryor WA, Squadrito GL, et al. (1999). Induction of inflammatory mediators in human airway epithelial cells by lipid ozonation products. Am J Respir Crit Care Med 160:1934-42. (Pubitemid 30004699)
15. Kopec SE, Irwin RS, Debellis RJ, et al. (2008). The effects of Tween-80 on the integrity of solutions of capsaicin: useful information for performing tussigenic challenges. Cough 4:3. DOI: 10.1186/1745- 9974-4-3.
16. Krishna MT, Springall D, Meng QH, et al. (1997). Effects of ozone on epithelium and sensory nerves in the bronchial mucosa of healthy humans. Am J Respir Crit Care Med 156:943-50. (Pubitemid 27396440)
17. LANUV NRW (Landesamt fur Natur, Umwelt und Verbraucherschutz Nordrhein-Westfalen). (2012). Kurzfassung der Jahreskenngroben 2011kontinuierlich gemessener Immissionskonzentrationen in NRW. Available from: http://www.lanuv.nrw.de/luft/immissionen/bertrend/ kontiJKG2011.pdf [Last accessed: 10 Apr 2013].
18. Lee LY, Widdicombe JG. (2001). Modulation of airway sensitivity to inhaled irritants: role of inflammatory mediators. Environ Health Perspect 109:585-9. (Pubitemid 32834574)
19. Lefohn AS, Hazucha MJ, Shadwick D, Adams WC. (2010). An alternative form and level of the human health ozone standard. Inhal Toxicol 22:999-1011.
20. Lippmann M. (1989). Health effects of ozone: a critical review. J Air Pollut Contr Assoc 39:672-95.
21. McDonnell WF. (2004). Use of submaximal inhalation and spirometry to assess the effects of ozone exposure. Arch Environ Health 59:76-83.
22. McDonnell WF, Stewart PW, Smith MV. (2010). Prediction of ozone-induced lung function responses in humans. Inhal Toxicol 22: 160-8.
23. McDonnell WF, Stewart PW, Smith MV, et al. (2012). Prediction of lung function response for populations exposed to a wide range of ozone conditions. Inhal Toxicol 24:619-33.
24. Midgren B, Hansson L, Karlsson JA, et al. (1992). Capsaicin-induced cough in humans. Am Rev Respir Dis 146:347-51.
25. Monsé C, Sucker K, van Thriel C, et al. (2012). Considerations for the design and technical setup of a human whole-body exposure chamber. Inhal Toxicol 24:99-108.
26. Morice AH, Fontana GA, Belvisi MG, et al. (2007). ERS guidelines on the assessment of cough. Eur Respir J 29:1256-76. (Pubitemid 46895388)
27. Mudway IS, Kelly FJ. (2004). An investigation of inhaled ozone dose and the magnitude of airway inflammation in healthy adults. Am J Respir Crit Care Med 169:1089-95. (Pubitemid 38624787)
28. Passannante AN, Hazucha MJ, Bromberg PA, et al. (1998). Nociceptive mechanisms modulate ozone-induced human lung function decrements. J Appl Physiol 85:1863-70. (Pubitemid 28516423)
29. Pellegrino R, Viegi G, Brusasco V, et al. (2005). Interpretative strategies for lung function tests. Eur Respir J 26:948-68. (Pubitemid 41632054)
30. Pisi G, Olivieri D, Chetta A. (2009). The airway neurogenic inflammation: clinical and pharmacological implications. Inflamm Allergy Drug Targets 8:176-81.
31. Pryor WA, Squadrito GL, Friedman M. (1995). The cascade mechanism to explain ozone toxicity: the role of lipid ozonation products. Free Radic Biol Med 19:935-41.
32. Quanjer PhH, Dalhuijsen A, Van Zomeben BC. (1983). Summary equations of reference values. Bull Eur Physiopathol Respir 19:45-51.
33. Schelegle ES, AdamsWC, Walby WF, Marion MS. (2012). Modelling of individual subject ozone exposure response kinetics. Inhal Toxicol 24: 401-15.
34. Schelegle ES, Siefkin AD, McDonald RJ. (1991). Time course of ozoneinduced neutrophilia in normal humans. Am Rev Respir Dis 143: 1353-8.
35. Seal Jr E, McDonnell WF, House DE, et al. (1993). The pulmonary response of white and black adults to six concentrations of ozone. Am Rev Respir Dis 147:804-10. (Pubitemid 23093799)
36. Ternesten-Hasseus E, Lowhagen O, Millqvist E. (2007). Quality of life and capsaicin sensitivity in patients with airway symptoms induced by chemicals and scents: a longitudinal study. Environ Health Perspect 115:425-9. (Pubitemid 46554442)